PHAT / Phathom Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Phathom Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US71722W1071

Deler fremragende 70,943,689 shares
Insideraktier25.710.234 shares
Insider ejerskab36,24 %
Total Insiders30
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-1 ( )

9712 out of 11301

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.004 %( )

9785 out of 11218

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Phathom Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Steven L Basta President and CEO, Director - [D] [O] 0 0
Branning Todd P. 0
Robert Charles Breedlove Principal Accounting Officer - [O] 47.931 47.931
Michael F Cola Director - [D] 39.798 39.798
Anne Marie Cook Chief Legal Off. & Corp. Sec. - [O] 0 0
Terrie Curran President and Chief Executive, Director - [D] [O] 360.465 360.465
Edwards Jonathan S. Director - [D] 47.984 47.984
Fhmls Ix, L.l.c. 10% Owner - [10%] 5.827.415 5.827.415
Fhmls Ix, L.p. 10% Owner - [10%] 5.827.415 5.827.415
Heidi Fields Director - [D] 30.000 30.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Frazier Life Sciences IX, L.P. 10% Owner - [10%] 5.827.415 5.827.415
Guzzo Anthony J. VP, Chief Accounting Officer - [O] 8.399 8.399
Molly Henderson CFO and CBO - [O] 89.868 89.868
Patrick J Heron 10% Owner - [10%] 5.827.415 5.827.415
Frank Karbe Director - [D] 67.500 67.500
Aditya Kohli Chief Business Officer - [O] 1.686.704 1.686.704
Peter Kolchinsky 10% Owner - [10%] 3.115.008 3.115.008
Ventures Management (Jersey) Ltd Medicxi 10% Owner - [10%] 61.975 61.975
Azmi Nabulsi Chief Operating Officer - [O] 1.101.869 1.101.869
Asit Parikh Director - [D] 113.500 113.500
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Ra Capital Management, Llc 10% Owner - [10%] 3.115.008 3.115.008
RA Capital Healthcare Fund LP 10% Owner - [10%] 3.115.008 3.115.008
Theodore R Schroeder Director - [D] 0 0
Shah Rajeev M. 10% Owner - [10%] 3.115.008 3.115.008
Slavinsky Christopher W. 0
David A Socks Director - [D] 19.500 19.500
Mark Stenhouse Director - [D] 30.000 30.000
Pharmaceutical Co Ltd Takeda 10% Owner - [10%] 3.755.583 3.755.583
James N Topper Director, 10% Owner - [D] [10%] 5.933.327 5.933.327
Tadataka Yamada Director, 10% Owner - [D] [10%] 3.373.408 3.373.408

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PHAT / Phathom Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-05-21 Topper James N 3.780 3,8649 3.780 3,8649 14.609 111 12.8900 34.115 233,52
2025-05-14 Topper James N 6.300 3,3205 6.300 3,3205 20.919
2025-05-13 Topper James N 1.120 3,1637 1.120 3,1637 3.543
2025-05-12 Topper James N 12.601 3,0395 12.601 3,0395 38.301
2025-05-09 Topper James N 2.226 3,6177 2.226 3,6177 8.053
2025-05-09 Topper James N 33.376 3,1928 33.376 3,1928 106.563
2025-05-07 Parikh Asit 5.000 2,3969 5.000 2,3969 11.984
2025-05-06 Parikh Asit 5.000 2,6000 5.000 2,6000 13.000
2025-03-13 Parikh Asit 10.000 4,4200 10.000 4,4200 44.200

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PHAT / Phathom Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PHAT / Phathom Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-09-05 Breedlove Robert Charles 461 12,0900 461 12,0900 5.573 11 10.9800 -511 -9,17
2025-07-16 Breedlove Robert Charles 1.692 8,3639 1.692 8,3639 14.152
2025-04-07 Henderson Molly 3.678 4,5513 3.678 4,5513 16.740
2025-01-21 Curran Terrie 19.109 6,5877 19.109 6,5877 125.884
2025-01-21 Nabulsi Azmi 7.886 6,5885 7.886 6,5885 51.957
2025-01-21 Henderson Molly 6.583 6,5883 6.583 6,5883 43.371
2024-12-19 Henderson Molly 1.291 8,0000 1.291 8,0000 10.328
2024-12-19 Nabulsi Azmi 1.118 8,0000 1.118 8,0000 8.944
2024-07-15 Nabulsi Azmi 10.901 11,7200 10.901 11,7200 127.760

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PHAT / Phathom Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-09-09 2025-09-05 4 Breedlove Robert Charles PHAT Common Stock S - Sale D 12,0900 -461 -6 47.931
2025-07-18 2025-07-16 4 Breedlove Robert Charles PHAT Common Stock S - Sale D 8,3639 -1.692 -14 48.392
2025-06-24 3 Cook Anne Marie PHAT No securities are beneficially owned. D 0
2025-06-05 2025-06-03 4 KARBE FRANK PHAT Common Stock A - Award D 10.500 67.500
2025-06-05 2025-06-03 4 COLA MICHAEL F PHAT Common Stock A - Award D 10.500 39.798
2025-06-05 2025-06-03 4 FIELDS HEIDI PHAT Common Stock A - Award D 10.500 30.000
2025-06-05 2025-06-03 4 Topper James N PHAT Common Stock A - Award D 10.500 42.596
2025-06-05 2025-06-03 4 Parikh Asit PHAT Common Stock A - Award D 10.500 113.500
2025-06-05 2025-06-03 4 Stenhouse Mark PHAT Common Stock A - Award D 10.500 30.000
2025-05-23 2025-05-21 4 Topper James N By Frazier Life Sciences X, L.P. PHAT Common Stock P - Purchase I 3,8649 3.780 15 59.403
2025-05-15 2025-05-14 4 Topper James N By Frazier Life Sciences X, L.P. PHAT Common Stock P - Purchase I 3,3205 6.300 21 55.623
2025-05-15 2025-05-13 4 Topper James N By Frazier Life Sciences X, L.P. PHAT Common Stock P - Purchase I 3,1637 1.120 4 49.323
2025-05-13 2025-05-12 4 Topper James N By Frazier Life Sciences X, L.P. PHAT Common Stock P - Purchase I 3,0395 12.601 38 48.203
2025-05-13 2025-05-09 4 Topper James N By Frazier Life Sciences X, L.P. PHAT Common Stock P - Purchase I 3,6177 2.226 8 35.602
2025-05-13 2025-05-09 4 Topper James N By Frazier Life Sciences X, L.P. PHAT Common Stock P - Purchase I 3,1928 33.376 107 33.376
2025-05-08 2025-05-07 4 Parikh Asit PHAT Common Stock P - Purchase D 2,3969 5.000 12 95.500
2025-05-08 2025-05-06 4 Parikh Asit PHAT Common Stock P - Purchase D 2,6000 5.000 13 90.500
2025-05-06 3 Breedlove Robert Charles PHAT Common Stock D 50.084
2025-05-06 3 Breedlove Robert Charles By 401(k) PHAT Common Stock I 5.108
2025-04-16 2025-04-16 4 Schroeder Theodore R PHAT Common Stock A - Award D 21.000 21.000
2025-04-16 3 Schroeder Theodore R PHAT No securities are beneficially owned. D 0
2025-04-08 2025-04-07 4 Henderson Molly PHAT Common Stock S - Sale D 4,5513 -3.678 -17 89.868
2025-04-03 3 Basta Steven L PHAT No securities are beneficially owned. D 0
2025-03-21 2024-09-10 4 Parikh Asit PHAT Common Stock M - Exercise D 11,7200 7.500 88 93.000
2025-03-17 2025-03-13 4 Parikh Asit PHAT Common Stock P - Purchase D 4,4200 10.000 44 85.500
2025-03-03 2025-02-27 4 Henderson Molly PHAT Common Stock A - Award D 72.000 165.546
2025-03-03 2025-02-27 4 Nabulsi Azmi PHAT Common Stock A - Award D 79.200 312.590
2025-01-23 2025-01-21 4 Henderson Molly PHAT Common Stock S - Sale D 6,5883 -6.583 -43 93.546
2025-01-23 2025-01-21 4 Nabulsi Azmi PHAT Common Stock S - Sale D 6,5885 -7.886 -52 233.390
2025-01-23 2025-01-21 4 Curran Terrie PHAT Common Stock S - Sale D 6,5877 -19.109 -126 360.465
2024-12-20 2024-12-19 4 Nabulsi Azmi PHAT Common Stock S - Sale D 8,0000 -1.118 -9 239.303
2024-12-20 2024-12-19 4 Henderson Molly PHAT Common Stock S - Sale D 8,0000 -1.291 -10 98.156
2024-12-16 2024-12-13 4 Parikh Asit PHAT Common Stock P - Purchase D 8,1248 10.000 81 75.500
2024-12-16 2024-12-13 4 KARBE FRANK PHAT Common Stock P - Purchase D 7,9267 12.500 99 57.000
2024-07-17 2024-07-15 4 Nabulsi Azmi PHAT Common Stock S - Sale D 11,7200 -10.901 -128 240.421
2024-07-17 2024-07-15 4 Henderson Molly PHAT Common Stock S - Sale D 11,7200 -4.325 -51 99.447
2024-07-17 2024-07-15 4 Curran Terrie PHAT Common Stock S - Sale D 11,7200 -33.848 -397 377.734
2024-05-31 2024-05-31 4 Henderson Molly PHAT Common Stoock A - Award D 7.500 102.763
2024-05-31 2024-05-31 4 Nabulsi Azmi PHAT Common Stoock A - Award D 7.500 249.567
2024-05-31 2024-05-29 4 KARBE FRANK PHAT Common Stock A - Award D 10,1645 25.000 254 44.500
2024-05-24 2024-05-23 4 Topper James N PHAT Common Stock A - Award D 10.500 32.096
2024-05-24 2024-05-23 4 Parikh Asit PHAT Common Stock A - Award D 10.500 65.500
2024-05-24 2024-05-23 4 COLA MICHAEL F PHAT Common Stock A - Award D 10.500 29.298
2024-05-24 2024-05-23 4 FIELDS HEIDI PHAT Common Stock A - Award D 10.500 19.500
2024-05-24 2024-05-23 4 KARBE FRANK PHAT Common Stock A - Award D 10.500 19.500
2024-05-24 2024-05-23 4 Stenhouse Mark PHAT Common Stock A - Award D 10.500 19.500
2024-05-24 2024-05-23 4 Socks David A PHAT Common Stock A - Award D 10.500 19.500
2024-04-10 2024-04-08 4 Henderson Molly PHAT Common Stoock S - Sale D 11,1000 -3.435 -38 95.263
2024-03-26 2024-03-22 4 Curran Terrie PHAT Common Stock S - Sale D 9,1100 -16.851 -154 410.784
2024-01-26 3 Medicxi Ventures Management (Jersey) Ltd By Medicxi IV LP PHAT Common Stock I 3.641.728
2024-01-26 3 Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth I LP PHAT Common Stock I 3.673.602
2024-01-26 3 Medicxi Ventures Management (Jersey) Ltd By Medicxi Co-Invest IV LP PHAT Common Stock I 61.975
2024-01-26 3 Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth Co-Invest I LP PHAT Common Stock I 87.267
2024-01-25 2024-01-24 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 8,1000 -3.703.703 -30.000 3.755.583
2024-01-22 2024-01-19 4 Henderson Molly PHAT Common Stock S - Sale D 7,7533 -6.307 -49 98.698
2023-11-21 2023-11-20 4 Henderson Molly PHAT Common Stock S - Sale D 7,2415 -2.127 -15 103.061
2023-11-08 2023-11-08 4 Parikh Asit PHAT Common Stock P - Purchase D 7,8000 2.500 20 55.000
2023-11-08 2023-11-07 4 Parikh Asit PHAT Common Stock P - Purchase D 7,7600 4.000 31 52.500
2023-11-08 2023-11-06 4 Parikh Asit PHAT Common Stock P - Purchase D 8,0400 1.000 8 48.500
2023-11-03 2023-11-01 4 Henderson Molly PHAT Common Stock S - Sale D 8,9500 -11.681 -105 105.188
2023-11-03 2023-11-01 4 Henderson Molly PHAT Common Stock S - Sale D 7,8000 -811 -6 116.869
2023-11-03 2023-11-01 4 Henderson Molly PHAT Common Stock A - Award D 22.500 117.680
2023-11-03 2023-11-01 4 Nabulsi Azmi PHAT Common Stock A - Award D 32.500 242.067
2023-11-03 2023-11-01 4 Curran Terrie PHAT Common Stock A - Award D 37.500 427.171
2023-07-21 2023-07-14 4/A Henderson Molly PHAT Common Stock A - Award D 25.000 95.180
2023-07-17 2023-07-14 4 Henderson Molly PHAT Common Stock A - Award D 1,0000 25.000 25 95.180
2023-07-17 2023-07-14 4 Curran Terrie PHAT Common Stock A - Award D 200.000 389.671
2023-07-17 2023-07-14 4 Nabulsi Azmi PHAT Common Stock A - Award D 110.000 209.567
2023-06-05 2023-06-02 4 Parikh Asit PHAT Common Stock A - Award D 7,4000 15.000 111 47.500
2023-06-05 2023-06-02 4 Henderson Molly PHAT Common Stock S - Sale D 11,4121 -1.960 -22 68.506
2023-05-30 2023-05-25 4 COLA MICHAEL F PHAT Common Stock A - Award D 9.000 18.798
2023-05-30 2023-05-25 4 Stenhouse Mark PHAT Common Stock A - Award D 9.000 9.000
2023-05-30 2023-05-25 4 Socks David A PHAT Common Stock A - Award D 9.000 9.000
2023-05-30 2023-05-25 4 Parikh Asit PHAT Common Stock A - Award D 9.000 32.500
2023-05-30 2023-05-25 4 FIELDS HEIDI PHAT Common Stock A - Award D 9.000 9.000
2023-05-30 2023-05-25 4 KARBE FRANK PHAT Common Stock A - Award D 9.000 9.000
2023-05-30 2023-05-25 4 Topper James N PHAT Common Stock A - Award D 9.000 21.596
2023-05-23 2023-05-22 4 Henderson Molly PHAT Common Stock S - Sale D 12,8744 -2.110 -27 70.466
2023-04-11 2023-04-11 4 Nabulsi Azmi PHAT Common Stock P - Purchase D 8,2600 10.000 83 99.567
2023-04-11 2023-04-10 4 Parikh Asit PHAT Common Stock P - Purchase D 7,5500 1.000 8 23.500
2023-04-07 2023-04-06 4 Curran Terrie PHAT Common Stock P - Purchase D 7,8199 12.919 101 188.290
2023-04-07 2023-04-06 4 Henderson Molly PHAT Common Stock S - Sale D 7,2700 -3.439 -25 72.576
2023-03-03 2023-03-01 4 Henderson Molly PHAT Common Stock S - Sale D 8,5309 -2.032 -17 76.015
2023-03-03 2023-03-01 4 Curran Terrie PHAT Common Stock S - Sale D 8,5411 -1.436 -12 175.371
2023-02-14 2023-02-13 4 Parikh Asit PHAT Common Stock P - Purchase D 7,7320 5.000 39 22.500
2023-01-20 2023-01-19 4 Nabulsi Azmi PHAT Common Stock A - Award D 45.000 89.567
2023-01-20 2023-01-20 4 Curran Terrie PHAT Common Stock S - Sale D 8,1995 -5.821 -48 176.807
2023-01-20 2023-01-19 4 Curran Terrie PHAT Common Stock A - Award D 97.500 182.628
2023-01-20 2023-01-19 4 Henderson Molly PHAT Common Stock A - Award D 33.000 78.047
2023-01-12 2023-01-12 4 Parikh Asit PHAT Common Stock P - Purchase D 7,0000 5.000 35 17.500
2022-11-23 2022-11-21 4 Curran Terrie PHAT Common Stock S - Sale D 9,6000 -1.526 -15 83.720
2022-11-23 2022-11-21 4 Henderson Molly PHAT Common Stock S - Sale D 9,6000 -2.159 -21 43.341
2022-09-02 2022-09-01 4 Nabulsi Azmi PHAT Common Stock A - Award D 7.500 41.971
2022-09-02 2022-09-01 4 Henderson Molly PHAT Common Stock A - Award D 7.500 45.500
2022-09-02 2022-09-01 4 Curran Terrie PHAT Common Stock A - Award D 7.500 85.246
2022-05-27 2022-05-25 4 COLA MICHAEL F PHAT Stock Option (Right to Buy) A - Award D 7,40 15.000 15.000
2022-05-27 2022-05-25 4 Stenhouse Mark PHAT Stock Option (Right to Buy) A - Award D 7,40 15.000 15.000
2022-05-27 2022-05-25 4 FIELDS HEIDI PHAT Stock Option (Right to Buy) A - Award D 7,40 15.000 15.000
2022-05-27 2022-05-25 4 Socks David A PHAT Stock Option (Right to Buy) A - Award D 7,40 15.000 15.000
2022-05-27 2022-05-25 4 Parikh Asit PHAT Stock Option (Right to Buy) A - Award D 7,40 15.000 15.000
2022-05-27 2022-05-25 4 KARBE FRANK PHAT Stock Option (Right to Buy) A - Award D 7,40 10.000 10.000
2022-05-20 2022-05-19 4 Nabulsi Azmi PHAT Common Stock A - Award D 12.000 33.378
2022-05-20 2022-05-19 4 Henderson Molly PHAT Common Stock A - Award D 12.000 38.000
2022-05-20 2022-05-19 4 Curran Terrie PHAT Common Stock A - Award D 12.000 76.595
2022-05-16 2022-05-16 4 Nabulsi Azmi by Trust PHAT Common Stock P - Purchase I 8,1644 20.000 163 785.700
2022-05-16 2022-05-13 4 Curran Terrie PHAT Common Stock P - Purchase D 7,4066 20.500 152 64.595
2022-05-16 2022-05-13 4 Henderson Molly PHAT Common Stock P - Purchase D 6.000 26.000
2022-05-16 2022-05-12 4 Parikh Asit PHAT Common Stock P - Purchase D 8,0000 12.500 100 12.500
2022-04-26 2022-04-25 4 KARBE FRANK PHAT Stock Option (Right to Buy) A - Award D 13,61 20.000 20.000
2022-04-06 2022-04-05 4 Henderson Molly PHAT Stock Option (Right to Buy) A - Award D 15,08 100.000 100.000
2022-04-06 2022-04-05 4 Henderson Molly PHAT Common Stock A - Award D 20.000 20.000
2022-03-16 2022-03-14 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Warrants X - Other D 0,00 -7.359.304 0
2022-03-16 2022-03-14 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 19,0000 -18 -0 7.459.286
2022-03-16 2022-03-14 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock X - Other D 7.359.304 7.459.304
2022-02-18 2019-10-29 4 COLA MICHAEL F PHAT Common Stock P - Purchase D 19,0000 9.798 186 9.798
2022-01-21 2022-01-19 4 Nabulsi Azmi PHAT Stock Option (Right to Buy) A - Award D 15,21 97.500 97.500
2022-01-21 2022-01-19 4 Nabulsi Azmi PHAT Common Stock A - Award D 19.500 21.378
2022-01-21 2022-01-19 4 Guzzo Anthony J. PHAT Stock Option (Right to Buy) A - Award D 15,21 30.000 30.000
2022-01-21 2022-01-19 4 Guzzo Anthony J. PHAT Common Stock A - Award D 6.000 8.399
2022-01-21 2022-01-19 4 Curran Terrie PHAT Stock Option (Right to Buy) A - Award D 15,21 206.250 206.250
2022-01-21 2022-01-19 4 Curran Terrie PHAT Common Stock A - Award D 41.250 44.095
2021-11-08 2021-11-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Warrants X - Other D 0,00 -228.696 7.359.304
2021-11-08 2021-11-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 20,8500 -1.000.000 -20.850 100.000
2021-11-08 2021-11-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 19,0000 -1 -0 1.100.000
2021-11-08 2021-11-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock X - Other D 228.696 1.100.001
2021-10-08 2021-10-08 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 32,0490 -2.529 -81 1.211.346
2021-10-08 2021-10-07 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 32,6639 -15.471 -505 1.213.875
2021-09-23 2021-09-22 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 32,0600 -4.100 -131 1.229.346
2021-09-23 2021-09-21 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 33,3058 -324 -11 1.233.446
2021-09-23 2021-09-21 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 32,7868 -13.576 -445 1.233.770
2021-08-18 2021-08-16 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 31,4907 -13.791 -434 1.247.346
2021-08-18 2021-08-16 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 30,4704 -4.209 -128 1.261.137
2021-07-14 2021-07-13 4 Parikh Asit PHAT Stock Option (Right to Buy) A - Award D 34,05 7.500 7.500
2021-07-09 2021-07-07 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0500 -2.609 -91 871.305
2021-07-06 2021-07-02 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0100 -100 -4 873.914
2021-07-06 2021-07-01 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,1600 -8.226 -289 874.014
2021-06-29 2021-06-29 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 34,0012 -13.960 -475 1.260.945
2021-06-29 2021-06-28 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 35,0869 -156 -5 1.274.905
2021-06-29 2021-06-28 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 34,0678 -25.884 -882 1.275.061
2021-06-29 2021-06-28 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0800 -370 -13 882.240
2021-06-29 2021-06-25 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,0700 -1.250 -45 882.610
2021-06-29 2021-06-25 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,4600 -22.881 -811 883.860
2021-06-25 2021-06-24 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,1400 -10.848 -381 906.741
2021-06-25 2021-06-23 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0000 -200 -7 917.589
2021-06-23 2021-06-22 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0000 -100 -4 917.789
2021-06-23 2021-06-21 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,3100 -9.294 -328 917.889
2021-06-21 2021-06-18 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,1300 -5.398 -190 927.183
2021-06-21 2021-06-17 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0800 -3.305 -116 932.581
2021-06-16 2021-06-14 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0600 -2.826 -99 935.886
2021-06-11 3 Guzzo Anthony J. PHAT Common Stock D 804
2021-06-11 2021-06-10 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,1400 -2.102 -74 938.712
2021-06-11 2021-06-09 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,2800 -1.191 -42 940.814
2021-06-09 2021-06-08 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0000 -100 -4 942.005
2021-06-09 2021-06-07 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0500 -2.264 -79 942.105
2021-06-04 2021-06-02 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,1800 -4.300 -151 944.369
2021-06-02 2021-06-01 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,2000 -3.967 -144 948.669
2021-06-02 2021-06-01 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,5500 -7.244 -258 952.636
2021-06-02 2021-05-28 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 37,5500 -2.104 -79 959.880
2021-06-02 2021-05-28 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,4000 -2.668 -97 961.984
2021-06-02 2021-05-28 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,3700 -4.133 -146 964.652
2021-05-28 2021-05-27 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 37,5500 -2.279 -86 968.785
2021-05-28 2021-05-27 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,9900 -6.174 -228 971.064
2021-05-28 2021-05-26 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,9200 -4.889 -181 977.238
2021-05-28 2021-05-26 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,4500 -7.469 -272 982.127
2021-05-26 2021-05-25 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,5900 -548 -20 989.596
2021-05-26 2021-05-25 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,1600 -10.399 -376 990.144
2021-05-26 2021-05-24 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,1000 -1.683 -61 1.000.543
2021-05-26 2021-05-24 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,5800 -8.911 -317 1.002.226
2021-05-24 2021-05-21 4 Yamada Tadataka PHAT Stock Option (Right to Buy) A - Award D 35,49 12.500 12.500
2021-05-24 2021-05-21 4 Socks David A PHAT Stock Option (Right to Buy) A - Award D 35,49 12.500 12.500
2021-05-24 2021-05-21 4 COLA MICHAEL F PHAT Stock Option (Right to Buy) A - Award D 35,49 12.500 12.500
2021-05-24 2021-05-21 4 Stenhouse Mark PHAT Stock Option (Right to Buy) A - Award D 35,49 12.500 12.500
2021-05-24 2021-05-21 4 Parikh Asit PHAT Stock Option (Right to Buy) A - Award D 35,49 12.500 12.500
2021-05-24 2021-05-21 4 FIELDS HEIDI PHAT Stock Option (Right to Buy) A - Award D 35,49 12.500 12.500
2021-05-24 2021-05-21 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,7400 -11.648 -416 1.011.137
2021-05-24 2021-05-20 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,1000 -7.098 -249 1.022.785
2021-05-21 2021-05-20 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 35,2662 -305 -11 1.300.945
2021-05-21 2021-05-20 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 34,9340 -2.278 -80 1.301.250
2021-05-21 2021-05-20 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 33,7606 -899 -30 1.303.528
2021-05-21 2021-05-19 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 33,3796 -3.229 -108 1.304.427
2021-05-21 2021-05-19 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 32,7836 -16.020 -525 1.307.656
2021-05-21 2021-05-19 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 31,9557 -17.269 -552 1.323.676
2021-05-18 2021-05-14 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0000 -100 -4 1.029.883
2021-05-14 2021-05-13 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,3300 -100 -4 1.029.983
2021-05-14 2021-05-12 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,0600 -905 -33 1.030.083
2021-05-14 2021-05-12 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,3900 -10.871 -385 1.030.988
2021-05-11 2021-05-07 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0300 -1.011 -35 1.041.859
2021-05-07 2021-05-06 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,0100 -202 -7 1.042.870
2021-05-07 2021-05-05 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,1400 -6.936 -244 1.043.072
2021-05-05 2021-05-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 38,5300 -100 -4 1.050.008
2021-05-05 2021-05-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 37,4700 -3.500 -131 1.050.108
2021-05-05 2021-05-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 36,2100 -4.690 -170 1.053.608
2021-05-05 2021-05-04 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 35,5000 -11.070 -393 1.058.298
2021-05-05 2021-05-03 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 39,0600 -203 -8 1.069.368
2021-05-05 2021-05-03 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 38,4500 -11.272 -433 1.069.571
2021-05-05 2021-05-03 4 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock S - Sale D 37,6000 -3.157 -119 1.080.843
2021-05-04 2021-05-04 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 37,8609 -1.089 -41 765.700
2021-05-04 2021-05-04 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 37,0866 -1.400 -52 766.789
2021-05-04 2021-05-04 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 36,1535 -1.968 -71 768.189
2021-05-04 2021-05-03 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 38,5876 -5.753 -222 770.157
2021-05-04 2021-05-03 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 37,8461 -4.290 -162 775.910
2021-04-07 2021-04-06 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 38,0302 -6.795 -258 1.340.945
2021-04-07 2021-04-06 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 37,3738 -6.328 -237 1.347.740
2021-04-07 2021-04-06 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 35,9698 -3.359 -121 1.354.068
2021-04-07 2021-04-06 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 34,9605 -1.400 -49 1.357.427
2021-04-07 2021-04-05 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 37,1532 -1.730 -64 1.358.827
2021-04-07 2021-04-05 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 36,4002 -7.769 -283 1.360.557
2021-04-07 2021-04-05 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 35,6872 -12.619 -450 1.368.326
2021-04-05 2021-04-05 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 37,1131 -785 -29 780.200
2021-04-05 2021-04-05 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 36,3656 -4.316 -157 780.985
2021-04-05 2021-04-05 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 35,6645 -4.252 -152 785.301
2021-04-05 2021-04-01 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 38,1411 -1.742 -66 789.553
2021-04-05 2021-04-01 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 37,2766 -3.405 -127 791.295
2021-03-23 2021-03-22 4 Curran Terrie PHAT Stock Option (Right to Buy) M - Exercise D 6,95 -11.513 855.687
2021-03-23 2021-03-22 4 Curran Terrie PHAT Common Stock S - Sale D 44,0838 -1.140 -50 0
2021-03-23 2021-03-22 4 Curran Terrie PHAT Common Stock S - Sale D 43,2368 -10.373 -448 1.140
2021-03-23 2021-03-22 4 Curran Terrie PHAT Common Stock M - Exercise D 6,9500 11.513 80 11.513
2021-03-15 2021-03-11 4 RA CAPITAL MANAGEMENT, LLC PHAT Common Stock S - Sale I 43,7500 -710.000 -31.062 3.115.008
2021-03-12 2021-03-12 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 46,6700 -500 -23 1.380.945
2021-03-12 2021-03-11 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 47,5367 -731 -35 1.381.445
2021-03-12 2021-03-11 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 47,1809 -41.698 -1.967 1.382.176
2021-03-12 2021-03-10 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 49,9303 -1.802 -90 1.423.874
2021-03-12 2021-03-10 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 49,0203 -7.844 -385 1.425.676
2021-03-12 2021-03-10 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 48,3163 -2.425 -117 1.433.520
2021-03-03 2021-03-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 46,2293 -2.070 -96 794.700
2021-03-03 2021-03-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 45,1722 -1.600 -72 796.770
2021-03-03 2021-03-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 46,7300 -24 -1 798.370
2021-03-03 2021-03-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 46,1576 -4.833 -223 798.394
2021-03-03 2021-03-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 44,5950 -600 -27 803.227
2021-03-03 2021-03-01 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 46,0549 -1.548 -71 803.827
2021-03-03 2021-03-01 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 45,7696 -3.825 -175 805.375
2021-02-23 2021-02-23 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 44,6967 -2.084 -93 1.435.945
2021-02-23 2021-02-23 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 43,3461 -1.881 -82 1.438.029
2021-02-23 2021-02-23 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 42,5018 -1.019 -43 1.439.910
2021-02-23 2021-02-22 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 46,9901 -1.417 -67 1.440.929
2021-02-23 2021-02-22 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 46,0250 -7.241 -333 1.442.346
2021-02-23 2021-02-22 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 45,2652 -11.482 -520 1.449.587
2021-02-23 2021-02-19 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 47,6100 -18.316 -872 1.461.069
2021-02-23 2021-02-19 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 47,0834 -21.360 -1.006 1.479.385
2021-02-23 2021-02-19 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 46,0207 -5.200 -239 1.500.745
2021-02-12 2020-12-01 5 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock G - Gift I -27.000 1.505.945
2021-02-03 2021-02-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 41,1626 -6.384 -263 809.200
2021-02-03 2021-02-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 40,5087 -2.700 -109 815.584
2021-02-03 2021-02-01 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 38,0881 -5.416 -206 818.284
2021-01-29 2021-01-28 4 Nabulsi Azmi PHAT Stock Option (Right to Buy) A - Award D 39,11 150.000 150.000
2021-01-29 2021-01-28 4 Branning Todd P. PHAT Stock Option (Right to Buy) A - Award D 39,11 60.000 60.000
2021-01-29 2021-01-28 4 Curran Terrie PHAT Stock Option (Right to Buy) A - Award D 39,11 225.000 225.000
2021-01-13 2021-01-12 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 36,1845 -20.091 -727 1.532.945
2021-01-13 2021-01-12 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 35,7382 -7.074 -253 1.553.036
2021-01-13 2021-01-11 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 34,9235 -12.835 -448 1.560.110
2021-01-05 2020-01-05 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 33,7694 -1.854 -63 823.700
2021-01-05 2020-01-04 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 34,5700 -100 -3 825.554
2021-01-05 2020-01-04 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 33,9332 -7.614 -258 825.654
2021-01-05 2020-01-04 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 33,0174 -4.932 -163 833.268
2020-12-18 2020-12-17 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 42,0000 -100 -4 1.572.945
2020-12-18 2020-12-17 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 41,4302 -12.915 -535 1.573.045
2020-12-18 2020-12-17 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 40,4894 -35.197 -1.425 1.585.960
2020-12-18 2020-12-16 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 48,9900 -200 -10 1.621.157
2020-12-18 2020-12-16 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 48,1900 -12.954 -624 1.621.357
2020-12-18 2020-12-16 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 47,3492 -13.292 -629 1.634.311
2020-12-18 2020-12-16 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 46,2205 -5.000 -231 1.647.603
2020-12-03 2020-12-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 45,5700 -2.995 -136 838.200
2020-12-03 2020-12-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 45,0500 -4.307 -194 841.195
2020-12-03 2020-12-01 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 44,8300 -1.828 -82 845.502
2020-12-03 2020-12-01 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 43,9900 -5.370 -236 847.330
2020-11-12 2020-11-11 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 40,3605 -903 -36 1.652.603
2020-11-12 2020-11-11 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 39,2240 -3.354 -132 1.653.506
2020-11-12 2020-11-11 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 38,1747 -2.620 -100 1.656.860
2020-11-12 2020-11-10 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 43,0700 -200 -9 1.659.480
2020-11-12 2020-11-10 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 42,3114 -4.601 -195 1.664.081
2020-11-12 2020-11-10 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 41,2923 -7.880 -325 1.668.682
2020-11-12 2020-11-09 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 44,0000 -100 -4 1.676.562
2020-11-12 2020-11-09 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 42,6663 -5.477 -234 1.676.662
2020-11-12 2020-11-09 4 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock S - Sale I 41,9478 -5.207 -218 1.682.139
2020-11-03 2020-11-02 4 Nabulsi Azmi By Trust PHAT Common Stock S - Sale I 36,8294 -14.500 -534 852.700
2020-11-03 2020-06-25 4 Nabulsi Azmi By Trust PHAT Common Stock G - Gift I 867.200 867.200
2020-11-03 2020-06-25 4 Nabulsi Azmi PHAT Common Stock G - Gift D -867.200 0
2020-07-13 2020-07-13 4 Branning Todd P. PHAT Stock Option (Right to Buy) A - Award D 29,43 85.000 85.000
2020-07-02 2020-07-01 4 Curran Terrie PHAT Stock Option (Right to Buy) A - Award D 32,20 175.000 175.000
2020-07-02 2020-07-01 4 Nabulsi Azmi PHAT Stock Option (Right to Buy) A - Award D 32,20 70.000 70.000
2020-06-16 2020-06-12 4 Frazier Life Sciences IX, L.P. PHAT Common Stock J - Other D -1.456.854 5.827.415
2020-05-22 2020-05-21 4 FIELDS HEIDI PHAT Stock Options A - Award D 36,85 10.000 10.000
2020-05-22 2020-05-21 4 Topper James N PHAT Stock Option A - Award D 36,85 10.000 10.000
2020-05-22 2020-05-21 4 Yamada Tadataka PHAT Stock Option A - Award D 36,85 10.000 10.000
2020-05-22 2020-05-21 4 COLA MICHAEL F PHAT Stock Option A - Award D 36,85 10.000 10.000
2020-04-03 2020-04-01 4 RA CAPITAL MANAGEMENT, LLC PHAT Common Stock P - Purchase I 24,8609 117.600 2.924 3.825.008
2020-03-31 2020-03-31 4 RA CAPITAL MANAGEMENT, LLC PHAT Common Stock P - Purchase I 24,5511 30.600 751 3.707.408
2020-03-31 2020-03-27 4 RA CAPITAL MANAGEMENT, LLC PHAT Common Stock P - Purchase I 24,6000 30.000 738 3.676.808
2020-03-19 2020-03-17 4 Stenhouse Mark PHAT Stock Option (Right to Buy) A - Award D 29,84 20.000 20.000
2020-02-06 3/A Shah Rajeev M. PHAT Common Stock I 3.646.808
2019-11-04 3 Shah Rajeev M. PHAT Common Stock I 7.293.292
2019-11-04 3 Shah Rajeev M. PHAT Common Stock I 7.293.292
2019-11-04 3 Shah Rajeev M. PHAT Common Stock I 7.293.292
2019-11-04 3 Shah Rajeev M. PHAT Common Stock I 7.293.292
2019-11-04 3 Shah Rajeev M. PHAT Common Stock I 7.293.292
2019-11-04 3 Shah Rajeev M. PHAT Common Stock I 7.293.292
2019-10-30 2019-10-29 4 Frazier Life Sciences IX, L.P. PHAT Convertible Promissory Notes C - Conversion D 0
2019-10-30 2019-10-29 4 Frazier Life Sciences IX, L.P. PHAT Common Stock P - Purchase D 19,0000 1.052.631 20.000 7.284.269
2019-10-30 2019-10-29 4 Frazier Life Sciences IX, L.P. PHAT Common Stock C - Conversion D 15,2000 1.353.640 20.575 6.231.638
2019-10-30 2019-10-29 4 Edwards Jonathan S. By Medicxi Growth Co-Invest I LP PHAT Convertible Promissory Notes C - Conversion I 15,20 0
2019-10-30 2019-10-29 4 Edwards Jonathan S. By Medicxi Growth I LP PHAT Convertible Promissory Notes C - Conversion I 15,20 0
2019-10-30 2019-10-29 4 Edwards Jonathan S. By Medicxi Growth Co-Invest I LP PHAT Common Stock P - Purchase I 19,0000 24.426 464 47.984
2019-10-30 2019-10-29 4 Edwards Jonathan S. By Medicxi Growth I LP PHAT Common Stock P - Purchase I 19,0000 1.028.205 19.536 2.019.877
2019-10-30 2019-10-29 4 Edwards Jonathan S. By Medicxi Growth Co-Invest I LP PHAT Common Stock C - Conversion I 15,2000 23.558 358 23.558
2019-10-30 2019-10-29 4 Edwards Jonathan S. By Medicxi Growth I LP PHAT Common Stock C - Conversion I 15,2000 991.672 15.073 991.672
2019-10-24 3 Heron Patrick J PHAT Common Stock D 9.755.996
2019-10-24 3 Heron Patrick J PHAT Common Stock D 9.755.996
2019-10-24 3 Heron Patrick J PHAT Common Stock D 9.755.996
2019-10-24 3 Heron Patrick J PHAT Common Stock D 9.755.996
2019-10-24 3 Heron Patrick J PHAT Common Stock D 9.755.996
2019-10-24 3 Heron Patrick J PHAT Common Stock D 9.755.996
2019-10-24 3 Heron Patrick J PHAT Common Stock D 9.755.996
2019-10-24 3 Nabulsi Azmi PHAT Common Stock D 1.734.400
2019-10-24 3 Nabulsi Azmi PHAT Common Stock D 1.734.400
2019-10-24 3 Nabulsi Azmi PHAT Common Stock D 1.734.400
2019-10-24 3 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock I 3.373.408
2019-10-24 3 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock I 3.373.408
2019-10-24 3 Socks David A David A. Socks 2013 Revocable Trust PHAT Common Stock I 3.373.408
2019-10-24 3 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock D 2.168.000
2019-10-24 3 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock D 2.168.000
2019-10-24 3 TAKEDA PHARMACEUTICAL CO LTD PHAT Common Stock D 2.168.000
2019-10-24 3 Yamada Tadataka PHAT Common Stock D 3.373.408
2019-10-24 3 Yamada Tadataka PHAT Common Stock D 3.373.408
2019-10-24 3 Yamada Tadataka PHAT Common Stock D 3.373.408
2019-10-24 3 Kohli Aditya PHAT Common Stock D 1.686.704
2019-10-24 3 Kohli Aditya PHAT Common Stock D 1.686.704
2019-10-24 3 Kohli Aditya PHAT Common Stock D 1.686.704
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista